Carl Zeiss Meditec continued its growth trend in the first quarter of 2016/17. Revenue increased by 6.6 percent.
The financial year 2015/16 was brought to a successful close with further growth: Revenue increased by 4.6 percent (adjusted for currency effects: 2.7 percent) to €1,088.4m.
ZEISS continues to set the pace in OCT innovation with Swept-Source OCT imaging.
ZEISS continues to strengthen its leadership team
Carl Zeiss Meditec AG is the parent company of the Carl Zeiss Meditec Group which also includes other subsidiaries. The Group is the focus for most of the medical technology business group's activity within the ZEISS organisation. The company is listed on TecDAX of the German stock exchange.
Find out more on our coporate website.
Carl Zeiss Meditec AG Website